407 related articles for article (PubMed ID: 32884236)
41. Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines.
Pourmoghadasiyan B; Tavakkoli F; Beram FM; Badmasti F; Mirzaie A; Kazempour R; Rahimi S; Larijani SF; Hejabi F; Sedaghatnia K
Mol Biol Rep; 2022 May; 49(5):3597-3608. PubMed ID: 35235156
[TBL] [Abstract][Full Text] [Related]
42. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Musende AG; Eberding A; Wood C; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Guns ET
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1085-95. PubMed ID: 19301006
[TBL] [Abstract][Full Text] [Related]
43. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
44. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats.
Lee WK; Kao ST; Liu IM; Cheng JT
Clin Exp Pharmacol Physiol; 2006; 33(1-2):27-32. PubMed ID: 16445695
[TBL] [Abstract][Full Text] [Related]
45. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.
Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H
Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724
[TBL] [Abstract][Full Text] [Related]
46. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
47. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats.
Lee WK; Kao ST; Liu IM; Cheng JT
Horm Metab Res; 2007 May; 39(5):347-54. PubMed ID: 17533576
[TBL] [Abstract][Full Text] [Related]
48. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
Popovich DG; Kitts DD
J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
[TBL] [Abstract][Full Text] [Related]
49. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting.
Bragagni M; Mennini N; Ghelardini C; Mura P
J Pharm Pharm Sci; 2012; 15(1):184-96. PubMed ID: 22365096
[TBL] [Abstract][Full Text] [Related]
50. [Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer].
Liu H; Liu Y; Li N; Zhang GQ; Wang M
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3472-3484. PubMed ID: 37474984
[TBL] [Abstract][Full Text] [Related]
51. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
[TBL] [Abstract][Full Text] [Related]
52. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
53. Influence of
Wang M; Li Q; Li S; Zhao Y; Jiang X; He S; Liu J
Foods; 2023 Oct; 12(21):. PubMed ID: 37959065
[TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes.
Barani M; Hajinezhad MR; Sargazi S; Rahdar A; Shahraki S; Lohrasbi-Nejad A; Baino F
J Mater Sci Mater Med; 2021 Dec; 32(12):147. PubMed ID: 34862910
[TBL] [Abstract][Full Text] [Related]
55. Construction of Ginsenoside Nanoparticles with pH/Reduction Dual Response for Enhancement of Their Cytotoxicity Toward HepG2 Cells.
Xu Y; Li X; Gong W; Huang HB; Zhu BW; Hu JN
J Agric Food Chem; 2020 Aug; 68(32):8545-8556. PubMed ID: 32686932
[TBL] [Abstract][Full Text] [Related]
56. A novel niosome formulation for encapsulation of anthocyanins and modelling intestinal transport.
Fidan-Yardimci M; Akay S; Sharifi F; Sevimli-Gur C; Ongen G; Yesil-Celiktas O
Food Chem; 2019 Sep; 293():57-65. PubMed ID: 31151649
[TBL] [Abstract][Full Text] [Related]
57. In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin.
Shilakari Asthana G; Sharma PK; Asthana A
Scientifica (Cairo); 2016; 2016():6492953. PubMed ID: 27293976
[TBL] [Abstract][Full Text] [Related]
58. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.
Jia WW; Bu X; Philips D; Yan H; Liu G; Chen X; Bush JA; Li G
Can J Physiol Pharmacol; 2004 Jul; 82(7):431-7. PubMed ID: 15389289
[TBL] [Abstract][Full Text] [Related]
59. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
60. Screening ginseng saponins in progenitor cells identifies 20(R)-ginsenoside Rh
Kim AR; Kim SW; Lee BW; Kim KH; Kim WH; Seok H; Lee JH; Um J; Yim SH; Ahn Y; Jin SW; Jung DW; Oh WK; Williams DR
Sci Rep; 2020 Mar; 10(1):4967. PubMed ID: 32188912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
